Hypersensitivity of Innate Response to Tlrs in Neonate

Yang-Xin Fu,Kwang Dong Kim,Jie Zhao,Sogyong Auh,Xuanming Yang,Hong Tang

DOI: https://doi.org/10.1096/fasebj.22.1_supplement.672.9

2008-01-01

Abstract:Neonates have high mortality and morbidity to infection, presumably due to a lack of fully developed adaptive and innate immune system. Injection of low dose of LPS mixed with D‐Galactosamine (D‐GalN) is a traditional “low dose LPS” model to study agonistic effects of this ligand of toll‐like receptor (TLR). Recent studies show that neonates are much more resistant to low dose LPS than adult mice, presumably caused by an impaired innate response in the newborn host. However, we have revealed neonatal mice were much more susceptible to LPS alone than adult mice, and such hypersensitivity extended to other TLR agonists including actual virus infection. We have now revealed that neonates survive better to low dose LPS likely because D‐GalN was more toxic to liver of adult than that of neonatal mice. Our data further showed that an uncontrolled innate immune response to TLR agonists or viral infection would be the direct cause of death in neonates. Therefore, the traditional low dose LPS model might not be an appropriate system to compare the innate responses in different ages or immunogenetic background. Remarkably, through transfer of T cells into neonates or depletion of T cells in young mice, we showed that T cells were necessary and sufficient to temper the early inflammatory response to LPS and protect neonates from death. Therefore, these results suggested that higher morbidity and mortality in neonates were caused by their lower number of T cells to mount sufficient inhibition of the early inflammation response by the innate cells, with important implication for new diagnosis and treatment for neonatal infection.